Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Appoints Gerard S. Carlozzi as Executive Vice President and Chief Operating Officer
Integra LifeSciences Appoints Gerard S. Carlozzi as Executive Vice President and Chief Operating Officer Plainsboro, NJ / September 25, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has appointed Gerard S. Carlozzi to the position of Executive Vice
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Neuron Therapeutics' Patent Estate
Integra LifeSciences Announces Acquisition of Neuron Therapeutics' Patent Estate Plainsboro, NJ / September 3, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has acquired the patent estate of Neuron Therapeutics, Inc.
View HTML
Toggle Summary Integra NeuroSciencesT Reports Positive Clinical Results from a Five Year Study of the OSVII™ Smart Valveä for the Treatment of Hydrocephalus
Integra NeuroSciencesT Reports Positive Clinical Results from a Five Year Study of the OSVIIÒ Smart Valveä for the Treatment of Hydrocephalus Results Indicate an Unsurpassed Long-Term Survival Rate in Hydrocephalus Patients Plainsboro, New Jersey, August 5, 2003-- Integra LifeSciences Holdings
View HTML
Toggle Summary Integra LifeSciences Reports Record Operating Earnings and Revenues for the Second Quarter 2003 (PDF)
Integra LifeSciences Reports Record Operating Earnings and Revenues for the Second Quarter 2003 (PDF) Click here for a printer friendly version. PLAINSBORO, NJ, July 31, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NasdaqNM: IART -- News) today reported net income of $5.4 million,
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-July 22, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that it has scheduled a
View HTML
Toggle Summary Court Upholds Integra LifeSciences Patents
Court Upholds Integra LifeSciences Patents Finding of Infringement by Merck KGaA upheld; Case Remanded For New Damages Calculation Plainsboro, NJ /June 9, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the United States Court of Appeals for the Federal
View HTML
Toggle Summary Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System
Integra LifeSciences Announces Launch of New and Improved External Ventricular Drainage System Plainsboro, New Jersey, May 1, 2003-Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced the release of a new and improved Hermetic PlusT external ventricular drainage system (EVD).
View HTML
Toggle Summary Positive Results Of DuraGen® Dural Graft Matrix Clinical Experience Involving 169 Patients Presented At AANS 2003 Annual Meeting In San Diego
Positive Results Of DuraGen® Dural Graft Matrix Clinical Experience Involving 169 Patients Presented At AANS 2003 Annual Meeting In San Diego Plainsboro, New Jersey, April 29, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Dr. Peter D.
View HTML
Toggle Summary Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego
Investigators Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at AANS 2003 Annual Meeting In San Diego Plainsboro, New Jersey, April 29, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that members of the Department of Neurosurgery and Surgery
View HTML
Toggle Summary Integra LifeSciences announces 1000th implant of NeuraGen™ Nerve Guide for Peripheral Nerve Repair
Integra LifeSciences announces 1000th implant of NeuraGenÔ Nerve Guide for Peripheral Nerve Repair Plainsboro, NJ / April 29, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported that more than 1,000 NeuraGenÔ Nerve Guides have been implanted in patients in the United
View HTML
Toggle Summary Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003
Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003 Cash Flows from Operations Totaled $8.8 Million PLAINSBORO, N.J., April 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NasdaqNM: IART - News) today reported net income of $5.4 million,
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes
Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes Plainsboro, New Jersey - April 11, 2003 - Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced that the initial purchasers of its 2.5% Contingent Convertible
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.-April 9, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that it has scheduled a
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes
Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes Plainsboro, New Jersey - March 26, 2003 - Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced that it has agreed to sell $100 million principal amount of its 2.5% contingent
View HTML
Toggle Summary Integra LifeSciences Confirms Earnings Guidance
Integra LifeSciences Confirms Earnings Guidance Plainsboro, NJ / March 26, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that the Company's guidance for earnings per share of $0.16 for the first quarter of 2003 remains unchanged.
View HTML